The page is the record's research on the issuer — no analyst, no rating, no view.

# Cellectis S.A. (NASDAQ: CLLS) — research page

As of 2026-11-08 · us-cm-kg · record version 1

## Identity and listing

The issuer is Cellectis S.A., listed on NASDAQ under ticker CLLS, with ISIN US15117K1034 and LEI 5493000KKX5VQ37Q2W83. Its security type is recorded as non-operating entity type (other), and its segment is not on the record. Its sector is 2836 Biological Products, (No Diagnostic Substances), and its jurisdiction is France. The issuer is listed and not halted.

## The disclosure read

The record holds 31 filings in the twelve months to 2026-11-08, falling on 25 filing days. The median gap between filing days is 8.0 days. The latest filing is dated 2026-10-28, is of type results, and is 11 days before the record date. The NASDAQ median cadence gap is 6.0 days across 4359 issuers, with a median of 52 filings and a median latency of 5.0 days. The sector median cadence gap is 5.5 days across 176 issuers, with a median of 65.5 filings and a median latency of 4.0 days. Of the 31 filings, 29 are results and 2 are regulatory filings.

## Auditor

The auditor of record is not on the record, because the latest annual report cover carries no dei:AuditorName tag, and the location is not on the record. The record holds no auditor changes.

## Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.

## Orderability

The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

## Coverage

The issuer's investor-relations page names 7 research houses: Barclays, Citizens Bank, Jefferies, Kempen, Oddo BHF, RW Baird and Wells Fargo.

## Open research

No openly published research notes were found on the pages read.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The vintage is sealed. The issuer's sealed years are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.

## Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- https://data.sec.gov/submissions/CIK0001627281.json (identity.jurisdiction)
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- https://mcp.us-cm-kg.ai/events/NASDAQ/CLLS (the disclosure lines)
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- https://www.cellectis.com/en/INVESTORS/ (coverage)
- https://mcp.us-cm-kg.ai/record/NASDAQ/CLLS (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/CLLS · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp